AU1646701A - Composition for treating respiratory tract infections - Google Patents

Composition for treating respiratory tract infections

Info

Publication number
AU1646701A
AU1646701A AU16467/01A AU1646701A AU1646701A AU 1646701 A AU1646701 A AU 1646701A AU 16467/01 A AU16467/01 A AU 16467/01A AU 1646701 A AU1646701 A AU 1646701A AU 1646701 A AU1646701 A AU 1646701A
Authority
AU
Australia
Prior art keywords
composition
respiratory tract
tract infections
treating respiratory
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16467/01A
Other languages
English (en)
Inventor
Jean Chatillon
Paul Ghislain Coupan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Top Pharm SARL
Original Assignee
Laboratoire Top Pharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Top Pharm SARL filed Critical Laboratoire Top Pharm SARL
Publication of AU1646701A publication Critical patent/AU1646701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
AU16467/01A 1999-11-10 2000-11-09 Composition for treating respiratory tract infections Abandoned AU1646701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9914102A FR2800614B1 (fr) 1999-11-10 1999-11-10 Composition pour le traitement des infections des voies respiratoires
FR9914102 1999-11-10
PCT/FR2000/003114 WO2001034182A2 (fr) 1999-11-10 2000-11-09 Composition pour le traitement des infections des voies respiratoires contenant le menthol, l'eucalyptol et une alpha-amylase

Publications (1)

Publication Number Publication Date
AU1646701A true AU1646701A (en) 2001-06-06

Family

ID=9551940

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16467/01A Abandoned AU1646701A (en) 1999-11-10 2000-11-09 Composition for treating respiratory tract infections

Country Status (3)

Country Link
AU (1) AU1646701A (fr)
FR (1) FR2800614B1 (fr)
WO (1) WO2001034182A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827776B1 (fr) * 2001-07-25 2005-09-30 Top Pharm Lab Composition comprenant un anti-inflammatoire enzymatique et un mucolytique
DE102006032233A1 (de) * 2006-07-12 2008-01-17 Ewabo Chemikalien Gmbh & Co. Kg Eukalyptol und Menthol enthaltende Zubereitung
FR2927256B1 (fr) * 2008-02-13 2010-05-14 Top Pharm Lab Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation
WO2010078392A2 (fr) * 2008-12-31 2010-07-08 Novozymes North America, Inc. Procédés de production de produits de fermentation
WO2019175782A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comportant des souches bactériennes et utilisation de celles-ci dans la surveillance de micro-organismes pathogènes
WO2019175783A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprenant des souches bactériennes et leur utilisation dans la régulation de micro-organismes pathogènes
WO2019175777A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprenant des souches bactériennes et leur utilisation pour lutter contre des micro-organismes pathogènes
WO2019175780A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprenant des souches bactériennes et utilisation correspondante pour lutter contre des micro-organismes pathogènes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740368A (en) * 1985-12-11 1988-04-26 Plevy Donald J Amylase containing breath cleansing confection

Also Published As

Publication number Publication date
FR2800614B1 (fr) 2002-01-04
WO2001034182A2 (fr) 2001-05-17
WO2001034182A3 (fr) 2002-04-04
FR2800614A1 (fr) 2001-05-11

Similar Documents

Publication Publication Date Title
AU2001253265A1 (en) Oral treatment systems
GB0125222D0 (en) Composition for the treatment of microbial infections
PL374831A1 (en) Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections
HUP0104255A3 (en) An pharmaceutical composition suitable for inhalation
AU7859800A (en) Topical nasal treatment
AU6908500A (en) Treatment for narcolepsy
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AUPQ466999A0 (en) Anaesthetic apparatus
AU2000276362A1 (en) Composition for the treatment of diabetes
AU1986099A (en) Device for inhaling medicament
AU1887401A (en) Medicinal composition
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
IL159585A0 (en) Single dose azithromycin for treating respiratory infections
AU5029700A (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
AU1646701A (en) Composition for treating respiratory tract infections
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU2021601A (en) Composition for the treatment of dandruff
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU2263801A (en) Quinolone compounds for use in treating viral infections
AU1878201A (en) Composition for the treatment of damaged tissue
AU2002364679A1 (en) Method and compositions for treating respiratory pathologies
AU2000231423A1 (en) Specific therapeutic composition for treating aids
AU5245600A (en) Medicinal compositions for treating lower uropathy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase